Recent Company News

• 07:08 AM ET May 14, 2025
  

  Centessa Pharmaceuticals reports Q1 EPS ($0.20) vs FactSet ($0.33) [10 est, ($0.48)-(0.20)] ($12.46, 0.00)

• 05:00 PM ET Feb 10, 2025
  

  StreetAccount Sector Summary - Healthcare Post-Market

• 08:58 AM ET May 08, 2025
  

  StreetAccount Sector Summary - Healthcare Pre-Market

• 05:12 AM ET May 08, 2025
  

  Centessa Pharmaceuticals initiated buy at Chardan Capital ($12.11, 0.00)

• 03:57 AM ET Mar 31, 2025
  

  Centessa Pharmaceuticals initiated overweight at Piper Sandler ($14.59, 0.00)

• 07:02 AM ET Mar 24, 2025
  

  Centessa Pharmaceuticals reports Q4 EPS ($0.84) vs FactSet ($0.42) [8 est, ($0.73)-(0.31)]

• 04:03 PM ET Feb 21, 2025
  

  Centessa Pharmaceuticals enters license agreement with Genmab A/S for LockBody platform ($16.63, 0.00)